In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated. As we navigate the complexities of these trials and the ...
Leap Therapeutics, Inc. (NASDAQ:LPTX) released significant updates regarding its recent clinical findings and corporate presentation. In a press release titled “Leap Therapeutics Reports Initial ...
Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced positive initial data from Part B of the DeFianCe study ...
Triumvira Immunologics, a clinical-stage company developing novel, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat patients with solid tumors ...
ClinChoice extends its 13-year partnership with Medidata to include advanced tools like Clinical Data Studio, enhancing data management and trial efficiency. This collaboration reinforces ClinChoice's ...
The clinical data from Theralase®'s international, multicenter Phase II ("BCG")-Unresponsive Non-Muscle Invasive Bladder Cancer ("NMIBC") Carcinoma In-Situ ("CIS") study will be presented by ...